GLOBUS MEDICAL, INC. Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
GLOBUS MEDICAL, INC. (GMED) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 0.00% for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Share-Based Payment Arrangement › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2026-08-06
- GLOBUS MEDICAL, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2026-03-31 was 0.00%.
- GLOBUS MEDICAL, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for the quarter ending 2025-03-31 was 0.00%.
- GLOBUS MEDICAL, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2018 was 0.00%.
- GLOBUS MEDICAL, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2017 was 0.00%.
- GLOBUS MEDICAL, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2016 was 0.00%.
- GLOBUS MEDICAL, INC. share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2015 was 0.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month |
|---|---|---|---|
| 2026-06-30 | 0.00% 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | 0.00% 10-Q · filed 2026-05-07 | ||
| 2025-06-30 | 0.00% 10-Q · filed 2026-08-06 | ||
| 2025-03-31 | 0.00% 10-Q · filed 2026-05-07 | ||
| 2018-12-31 | 0.00% 10-K · filed 2019-02-21 | ||
| 2017-12-31 | 0.00% 10-K · filed 2019-02-21 | ||
| 2016-12-31 | 0.00% 10-K · filed 2019-02-21 | ||
| 2015-12-31 | 0.00% 10-K · filed 2018-02-22 | ||
| 2014-12-31 | 0.00% 10-K · filed 2017-03-16 | ||
| 2013-12-31 | 0.00% 10-K · filed 2016-02-29 | ||
| 2012-12-31 | 0.00% 10-K · filed 2015-02-26 | ||
| 2011-12-31 | 0.00% 10-K · filed 2014-03-14 | ||
| 2010-12-31 | 0.00% 10-K/A · filed 2013-06-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| Heartflow, Inc. (HTFL) | United States | $4.225B |